Unknown

Dataset Information

0

Shox2 is a molecular determinant of depot-specific adipocyte function.


ABSTRACT: Visceral and s.c. fat exhibit different intrinsic properties, including rates of lipolysis, and are associated with differential risk for the development of type 2 diabetes. These effects are in part related to cell autonomous differences in gene expression. In the present study, we show that expression of Shox2 (Short stature homeobox 2) is higher in s.c. than visceral fat in both rodents and humans and that levels are further increased in humans with visceral obesity. Fat-specific disruption of Shox2 in male mice results in protection from high fat diet-induced obesity, with a preferential loss of s.c. fat. The reduced adipocyte size is secondary to a twofold increase in the expression of ?3 adrenergic receptor (Adrb3) at both the mRNA and protein level and a parallel increase in lipolytic rate. These effects are mimicked by knockdown of Shox2 in C3H10T1/2 cells. Conversely, overexpression of Shox2 leads to a repression of Adrb3 expression and decrease lipolytic rate. Shox2 does not affect differentiation but directly interacts with CCAAT/enhancer binding protein alpha and attenuates its transcriptional activity of the Adrb3 promoter. Thus, Shox2 can regulate the expression of Adrb3 and control the rate of lipolysis and, in this way, exerts control of the phenotypic differences between visceral and s.c. adipocytes.

SUBMITTER: Lee KY 

PROVIDER: S-EPMC3710789 | biostudies-literature | 2013 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Shox2 is a molecular determinant of depot-specific adipocyte function.

Lee Kevin Y KY   Yamamoto Yuji Y   Boucher Jeremie J   Winnay Jonathon N JN   Gesta Stephane S   Cobb John J   Blüher Matthias M   Kahn C Ronald CR  

Proceedings of the National Academy of Sciences of the United States of America 20130624 28


Visceral and s.c. fat exhibit different intrinsic properties, including rates of lipolysis, and are associated with differential risk for the development of type 2 diabetes. These effects are in part related to cell autonomous differences in gene expression. In the present study, we show that expression of Shox2 (Short stature homeobox 2) is higher in s.c. than visceral fat in both rodents and humans and that levels are further increased in humans with visceral obesity. Fat-specific disruption o  ...[more]

Similar Datasets

| S-EPMC5358705 | biostudies-literature
| S-EPMC4380653 | biostudies-literature
| S-EPMC7012762 | biostudies-literature
| S-EPMC5477735 | biostudies-literature
| S-EPMC7052157 | biostudies-literature
| S-EPMC2661589 | biostudies-literature
| S-EPMC8470180 | biostudies-literature
| S-EPMC7963095 | biostudies-literature
| S-EPMC6333440 | biostudies-literature
| S-EPMC6216059 | biostudies-literature